|1||Active, not recruiting||
A Safety Study of SGN-CD19A for B-Cell Lymphoma
|2||Active, not recruiting||
A Safety Study of SGN-CD19A for Leukemia and Lymphoma
Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma
Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma
† Study has passed its completion date and status has not been verified in more than two years.